David Schult
University Hospital Heidelberg
7 Papers
9 Citations
David Schult is an academic researcher from University Hospital Heidelberg. The author has contributed to research in topics: Transplantation & Prospective cohort study. The author has an hindex of 4, co-authored 7 publications. Previous affiliations of David Schult include Heidelberg University.
Chat about Author
Papers
Predicting sinusoidal obstruction syndrome after allogeneic stem cell transplantation with the EASIX biomarker panel
Sihe Jiang,Olaf Penack,Tobias Terzer,David Schult,Joshua Majer-Lauterbach,Aleksandar Radujkovic,Igor Wolfgang Blau,Lars Bullinger,Carsten Müller-Tidow,Peter Dreger,Thomas Luft +10 more
TL;DR: EASIX-d0 is the first validated biomarker for defining a subpopulation of alloSCT recipients at high risk for SOS/VOD, and Statin/UDA endothelial prophylaxis could constitute aProphylactic measure for patients at increased SOS/ VOD risk.
Completion rate and impact on physician-patient relationship of video consultations in medical oncology: a randomised controlled open-label trial.
Thomas Walle,Erkin Erdal,Leon Mühlsteffen,Hans Martin Singh,Editha Gnutzmann,Barbara Grün,Helene Hofmann,Alexandra Ivanova,Bruno Köhler,Felix Korell,Athanasios Mavratzas,Andreas Mock,Constantin Pixberg,David Schult,Helen Starke,Niels Steinebrunner,Lena Woydack,Andreas Schneeweiss,Mareike Dietrich,Dirk Jäger,Johannes Krisam,Jakob Nikolas Kather,Eva C. Winkler +22 more
- 01 Nov 2020
TL;DR: Follow-up visits with the tested mobile phone video call application were feasible but software compatibility should be critically evaluated.
28
Interleukin-18 and outcome after allogeneic stem cell transplantation: A retrospective cohort study.
Aleksandar Radujkovic,Lambros Kordelas,Hao Dai,David Schult,Joshua Majer-Lauterbach,Dietrich W. Beelen,Carsten Müller-Tidow,Peter Dreger,Thomas Luft +8 more
TL;DR: Higher pre-transplant levels of free IL-18 were associated with non-relapse and overall mortality after alloSCT, and may provide a rationale for prospective studies evaluating IL- 18 status and inhibition of IL-16 activity in patients undergoing allografting.
12
Early bilirubinemia after allogeneic stem cell transplantation-an endothelial complication.
Hao Dai,Olaf Penack,Aleksandar Radujkovic,David Schult,Joshua Majer-Lauterbach,Igor Wolfgang Blau,Lars Bullinger,Sihe Jiang,Carsten Müller-Tidow,Peter Dreger,Thomas Luft +10 more
TL;DR: In this article, the impact of early bilirubinemia (EB) on posttransplant outcomes was investigated using maximally selected log rank statistics to identify a cut off for the endpoint non-relapse mortality (NRM).
Pre-transplant testosterone and outcome of men after allogeneic stem cell transplantation.
Aleksandar Radujkovic,Lambros Kordelas,Julia Krzykalla,Axel Benner,David Schult,Joshua Majer-Lauterbach,Dietrich W. Beelen,Carsten Müller-Tidow,Christian Kasperk,Peter Dreger,Thomas Luft +10 more
TL;DR: The impact of pre-transplant testosterone levels on outcome in male patients undergoing alloSCT for AML is evaluated to provide a rationale for prospective studies on testosterone/androgen assessment and supplementation.
3